These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 21077342

  • 1. [Immunosuppressive therapies for refractory nephrotic syndrome].
    Mitarai T.
    Nihon Jinzo Gakkai Shi; 2010; 52(7):924-7. PubMed ID: 21077342
    [No Abstract] [Full Text] [Related]

  • 2. [Immunosuppressive therapy for nephrotic syndrome and strategy for adverse side effects from that therapy].
    Takeda Y, Tomino Y.
    Nihon Rinsho; 2004 Oct; 62(10):1875-9. PubMed ID: 15500133
    [Abstract] [Full Text] [Related]

  • 3. [Immunosuppressive therapy update 2010 for ANCA-associated glomerulonephritis and intractable nephrotic syndrome].
    Yoshida M.
    Nihon Jinzo Gakkai Shi; 2010 Oct; 52(1):1-9. PubMed ID: 20166533
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment guidelines for the idiopathic nephrotic syndrome in children].
    Yoshikawa N, Honda M, Sekine K, Nakanishi K, Iijima I, Ootomo Y, Ikeda M, Wada N, Nakamura H, Sako M, Japanese Society of Nephrology Committee for Development of Guidelines for Drug Therapy for Nephrotic Syndrome in Children.
    Nihon Jinzo Gakkai Shi; 2005 Oct; 47(7):790-803. PubMed ID: 16296409
    [No Abstract] [Full Text] [Related]

  • 5. Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab.
    Sharma AP, Filler G.
    Pediatr Nephrol; 2009 Feb; 24(2):423-4. PubMed ID: 18853197
    [No Abstract] [Full Text] [Related]

  • 6. Non-steroidal and non-cytotoxic therapies for nephrotic syndrome.
    Coppo R.
    Nephrol Dial Transplant; 2008 Jun; 23(6):1793-6. PubMed ID: 18441003
    [No Abstract] [Full Text] [Related]

  • 7. [Molecular action mechanisms of the therapeutic agents for kidney diseases: Immunosuppressants].
    Nishikido M, Kanekake H, Harada T.
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():634-8. PubMed ID: 16523968
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Low-dose ofatumumab for rituximab-resistant nephrotic syndrome.
    Bonanni A, Rossi R, Murtas C, Ghiggeri GM.
    BMJ Case Rep; 2015 Sep 16; 2015():. PubMed ID: 26376698
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
    Kurasawa T, Nagasawa H, Nishi E, Takei H, Okuyama A, Kondo T, Nishimura K, Sakai R, Shibata A, Chino K, Ogawa H, Ito T, Amano K, Kato H.
    Intern Med; 2013 Sep 16; 52(10):1125-30. PubMed ID: 23676603
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of steroid-resistant polymyositis and dermatomyositis].
    Mimura T, Kanda H, Kubo K.
    Nihon Rinsho; 2001 Oct 16; 59(10):2062-70. PubMed ID: 11676154
    [Abstract] [Full Text] [Related]

  • 15. Should we consider MMF therapy after rituximab for nephrotic syndrome?
    Filler G, Huang SH, Sharma AP.
    Pediatr Nephrol; 2011 Oct 16; 26(10):1759-62. PubMed ID: 21533869
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Maintenance therapy with single-daily, high-dose mizoribine after cyclophosphamide therapy for prepubertal boys with severe steroid-dependent nephrotic syndrome.
    Fujinaga S, Endo A, Watanabe T, Hirano D, Ohtomo Y, Shimizu T, Kaneko K.
    Clin Nephrol; 2012 Sep 16; 78(3):251-2. PubMed ID: 22541687
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunosuppression in the post-adaptation period.
    Halloran PF.
    Transplantation; 2000 Jul 15; 70(1):3-5. PubMed ID: 10919566
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.